Publications by authors named "Stephane Lorenc"

Claim this Profile
W
Workplace Vaccination Against COVID-19 and Seasonal Influenza in the United States: A Modeling-Based Estimation of the Health and Economic Benefits for Employers and Employees.
Ekkehard Beck, Keya Joshi, Darshan Mehta, Stephane Lorenc, Bishoy Rizkalla

J Mark Access Health Policy· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Public health impact of recombinant zoster vaccine for prevention of herpes zoster in US adults immunocompromised due to cancer.
Desmond Curran, Brandon J Patterson, Justin Carrico, Ahmed Salem, Elizabeth M La, Stéphane Lorenc

Hum Vaccin Immunother· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-Effectiveness of Recombinant Zoster Vaccine for the Prevention of Herpes Zoster in Hematopoietic Stem Cell Transplant Recipients and Other Immunocompromised Adults in the United States.
Ahmed Salem, Elizabeth M La, Desmond Curran, Brandon J Patterson, Justin Carrico, Stéphane Lorenc

Pharmacoecon Open· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of the recombinant zoster vaccine in the German population aged ≥60 years old.
Desirée Van Oorschot, Anastassia Anastassopoulou, Barbara Poulsen Nautrup, Lijoy Varghese, Alfred von Krempelhuber, Stéphane Lorenc

Hum Vaccin Immunother· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Public health impact model estimating the impact of introducing an adjuvanted recombinant zoster vaccine into the UK universal mass vaccination programme.
Desirée A M van Oorschot, Manjit Hunjan, Benjamin Bracke, Stéphane Lorenc, Desmond Curran

BMJ Open· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis